2022 Week 33: Johnson & Johnson (NYSE: JNJ)

Portfolio Update

The FiveTwenty portfolio received $25.92 dividends in the past week. APD paid its quarterly dividend during the week.

Past Week Dividend$25.92
Current Quarter Dividend (Q3 2022)$384.59
LifeTime Dividend$4,991.75
Estimated Annual Dividend$6,112.25
Dividend Scorecard

The capital allocation for the week of 08/14/2022 to 08/20/2022 will be used to add to our position in Johnson & Johnson (NYSE: JNJ)

JNJ – Position Update

Since our last check-in on JNJ in week 32 of 2022, there have been no significant financial developments for the company. The share price decreased 3.4% from $171.11 to $165.30 during the period.

TTMPrev. Update10-year median
Dividend Streak60 years60 years
Yield2.61%2.52%2.66%
Payout Ratio43.14%143.14%1
P/E16.55117.131
Entry Criteria Scorecard

1 computed using TTM adjusted EPS of $9.99 as of Q2 2022

Q2 2022 earnings report

Did JNJ’s latest earnings report raise any warning flags?

We discussed JNJ’s financial performance during Q2 2022 in our previous update. Overall, revenues grew 3%, adjusted net income increased 4.3%, and adjusted EPS were 4.4% higher than in Q2 2021.

Revenue
(in millions)
Adj. Net Income
(in millions)
Adj. EPS
.
Q2 2021$23,321$6,625$2.48
Q2 2022$24,020$6,912$2.59
% Change3%4.3%4.4%

Additional noteworthy developments during the quarter:

Thesis

Why are we adding to our position in JNJ?

With no significant developments for JNJ in the last week, our investment thesis remains the same. We therefore continue to build out our position in the company.

Previous Articles


Photo by Arthur Pereira on Unsplash

One Reply to “2022 Week 33: Johnson & Johnson (NYSE: JNJ)”

Comments are closed.